Free Trial

Quoin Pharmaceuticals (QNRX) Competitors

Quoin Pharmaceuticals logo
$14.89 +1.35 (+9.97%)
Closing price 10/17/2025 04:00 PM Eastern
Extended Trading
$14.80 -0.09 (-0.60%)
As of 10/17/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

QNRX vs. DRIO, POCI, MODD, STRR, NRXS, CLGN, RVP, VVOS, NXL, and COCH

Should you be buying Quoin Pharmaceuticals stock or one of its competitors? The main competitors of Quoin Pharmaceuticals include DarioHealth (DRIO), Precision Optics (POCI), Modular Medical (MODD), Star Equity (STRR), NeurAxis (NRXS), CollPlant Biotechnologies (CLGN), Retractable Technologies (RVP), Vivos Therapeutics (VVOS), Nexalin Technology (NXL), and Envoy Medical (COCH). These companies are all part of the "medical equipment" industry.

Quoin Pharmaceuticals vs. Its Competitors

Quoin Pharmaceuticals (NASDAQ:QNRX) and DarioHealth (NASDAQ:DRIO) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, media sentiment, profitability, dividends, earnings and analyst recommendations.

8.6% of Quoin Pharmaceuticals shares are owned by institutional investors. Comparatively, 33.4% of DarioHealth shares are owned by institutional investors. 13.5% of Quoin Pharmaceuticals shares are owned by insiders. Comparatively, 11.2% of DarioHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Quoin Pharmaceuticals has a beta of 1.66, meaning that its share price is 66% more volatile than the S&P 500. Comparatively, DarioHealth has a beta of 1.31, meaning that its share price is 31% more volatile than the S&P 500.

DarioHealth has a consensus target price of $40.00, suggesting a potential upside of 206.98%. Given DarioHealth's stronger consensus rating and higher possible upside, analysts plainly believe DarioHealth is more favorable than Quoin Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quoin Pharmaceuticals
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
DarioHealth
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

In the previous week, Quoin Pharmaceuticals had 5 more articles in the media than DarioHealth. MarketBeat recorded 7 mentions for Quoin Pharmaceuticals and 2 mentions for DarioHealth. Quoin Pharmaceuticals' average media sentiment score of 0.55 beat DarioHealth's score of 0.25 indicating that Quoin Pharmaceuticals is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Quoin Pharmaceuticals
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
DarioHealth
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Quoin Pharmaceuticals has a net margin of 0.00% compared to DarioHealth's net margin of -162.73%. DarioHealth's return on equity of -65.89% beat Quoin Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Quoin PharmaceuticalsN/A -210.50% -99.41%
DarioHealth -162.73%-65.89%-39.03%

Quoin Pharmaceuticals has higher earnings, but lower revenue than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than Quoin Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Quoin PharmaceuticalsN/AN/A-$8.96M-$41.45-0.36
DarioHealth$27.04M1.09-$42.75M-$13.20-0.99

Summary

DarioHealth beats Quoin Pharmaceuticals on 8 of the 15 factors compared between the two stocks.

Get Quoin Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for QNRX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QNRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QNRX vs. The Competition

MetricQuoin PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$8.76M$3.02B$6.21B$10.54B
Dividend YieldN/A54.20%5.70%4.81%
P/E Ratio-0.3623.3185.7027.13
Price / SalesN/A588.05582.68179.32
Price / CashN/A169.4137.1060.81
Price / Book0.425.3212.236.52
Net Income-$8.96M$33.06M$3.33B$276.93M
7 Day Performance-27.37%2.29%1.17%1.93%
1 Month Performance93.38%7.35%6.85%2.19%
1 Year Performance-49.95%-5.13%58.93%34.62%

Quoin Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QNRX
Quoin Pharmaceuticals
1.7278 of 5 stars
$14.89
+10.0%
N/A-49.9%$8.76MN/A-0.364News Coverage
Analyst Forecast
Insider Trade
DRIO
DarioHealth
2.062 of 5 stars
$14.38
-3.7%
$40.00
+178.2%
-36.7%$32.64M$27.04M-1.09200Gap Down
POCI
Precision Optics
0.234 of 5 stars
$4.23
-0.2%
N/A-1.2%$32.61M$19.09M-5.0480
MODD
Modular Medical
1.1074 of 5 stars
$0.58
-5.8%
N/A-73.9%$32.01MN/A-1.1420Analyst Forecast
Short Interest ↓
Gap Up
High Trading Volume
STRR
Star Equity
1.1071 of 5 stars
$11.13
-0.9%
$5.00
-55.1%
+173.0%$30.66M$137.86M-8.561,300
NRXS
NeurAxis
1.9936 of 5 stars
$3.03
-1.3%
$7.00
+131.0%
-1.3%$29.92M$3.22M-1.6519
CLGN
CollPlant Biotechnologies
1.9367 of 5 stars
$2.32
+3.6%
$11.50
+395.7%
-44.6%$29.51M$510K-2.0570News Coverage
Gap Up
RVP
Retractable Technologies
2.478 of 5 stars
$0.92
-5.2%
N/A+21.5%$27.46M$38.16M-1.70240News Coverage
Positive News
Short Interest ↓
VVOS
Vivos Therapeutics
1.5273 of 5 stars
$3.18
+0.3%
$4.92
+54.6%
+8.6%$23.85M$15.03M-1.89160Negative News
Short Interest ↑
NXL
Nexalin Technology
2.6131 of 5 stars
$1.29
-3.7%
$5.00
+287.6%
+20.6%$22.77M$170K-1.703Short Interest ↓
COCH
Envoy Medical
2.0289 of 5 stars
$0.92
+2.2%
$9.50
+934.5%
-69.5%$21.87M$220K-0.6434

Related Companies and Tools


This page (NASDAQ:QNRX) was last updated on 10/19/2025 by MarketBeat.com Staff
From Our Partners